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ABSTRACT:
The problems Parkinson’s disease (PD) patients en-
counter when admitted to a hospital, are known to be
numerous and serious. These problems have been
inventoried through a systematic review of literature on
reasons for emergency and hospital admissions in PD
patients, problems encountered during hospitalization,
and possible solutions for the encountered problems
using the Pubmed database. PD patients are hospital-
ized in frequencies ranging from 7 to 28% per year.
PD/parkinsonism patients are approximately one and a
half times more frequently and generally 2 to 14 days
longer hospitalized than non-PD patients. Acute events
occurring during hospitalization were mainly urinary
infection, confusion, and pressure ulcers. Medication
errors were also frequent adverse events. During and
after surgery PD patients had an increased incidence
of infections, confusion, falls, and decubitus, and 31%
of patients was dissatisﬁed in the way their PD was
managed. There are only two studies on medication
continuation during surgery and one analyzing the
effect of an early postoperative neurologic consulta-
tion, and numerous case reports, and opinionated
views and reviews including other substitutes for do-
paminergic medication intraoperatively. In conclusion,
most studies were retrospective on small numbers of
patients. The major clinical problems are injuries, infec-
tions, poor control of PD, and complications of PD
treatment. There are many (un-researched) proposals
for improvement. A substantial number of PD patients’
admissions might be prevented. There should be
guidelines concerning the hospitalized PD patients,
with accent on early neurological consultation and
team work between different specialities, and incorpo-
rating nonoral dopaminergic replacement therapy when
necessary. V C 2011 Movement Disorder Society
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Introduction
Parkinson’s disease (PD) is the second most common
neurodegenerative disorder with a life-time risk of 2
percent in men and 1.3 percent in women.
1 Although
the disorder is generally slowly progressive, it does have
a major impact on disability and quality of life of
affected patients.
2,3 One of the lesser studied aspects of
PD is the spectrum of problems PD patients encounter,
once they are admitted to a hospital. In our own and
others’ experience hospital admissions of PD patients
are often problematic, especially so when patients are
admitted on non-neurological wards.
4,5 Problem areas
are exact timing or lack of drug administration, admin-
istration of contra-indicated drugs, complications due to
immobilization, and psychiatric disorders triggered by
the hospital admission.
6–8 As most non-neurologically
educated health care personnel are unfamiliar with PD,
protocols would be helpful to improve the care of PD
patients in such environments.
We recently surveyed the majority of movement
disorder specialist neurologists in the Netherlands
and found that no speciﬁc guidelines or protocols
exist to guide caregivers and PD patients in the hos-
pital environment (manuscript in preparation). Before
such guidelines can be formulated, one needs to
know the prevalence and spectrum of the problems
PD patients may experience during their hospital
stay. To this end, we systemically reviewed all the
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the hospitalized PD patients.
Methods
We systematically reviewed the literature on reasons
for emergency room (ER) and hospital admissions in
patients with PD, problems encountered during hospi-
talization of this patient population, and possible solu-
tions for the encountered problems, using the Pubmed
database. Last research date was 17 June 2010.
To identify articles, we included (combinations of)
keywords: See Table 1 for search details. Subsequently
we analyzed the abstracts for relevant articles: as rele-
vant articles we deﬁned those as pertaining to the fol-
lowing four areas:
1. Analysis of prevalence and reasons for ER visits
and subsequent admission.
2. Clinical problems during hospital stay.
3. Peri- and postoperative problems.
4. Suggestions for improvement of care for the hos-
pitalized PD patient.
We also searched the reference list of each relevant
article for other applicable articles.
In our search, there were no language limitations.
We excluded articles concerning brain surgery.
Results
Emergency Room and Hospital Admissions
Patients with PD often need emergency treatment.
There are four studies analyzing the reasons for ER
admission,
4,9–11 including one case report
11 (totaling
327 PD patients, Table 2). A total of 16–45% of PD
patients visit an ER once a year.
9,10,12,13 PD patients
visit the ER more frequently than their matched refer-
ence group (0.6 vs. 0.4; P ¼ 0.05).
14
We found 12 studies on hospital admissions (Table
3): 11 studies totalling 3216 PD/parkinsonism
patients,
4,9,10,13,15–19,21,22 and one study
20 on a data-
base with 15304 PD/parkinsonism patients. In these
studies, PD patients are hospitalized in frequencies
ranging from 7–28% per year.
9,10,15,19,20
PD/parkinsonism patients are hospitalized approxi-
mately one and a half times more frequently
20,23,24
and generally 2 to 14 days longer
12,16,17,19,21,24–29
than non-PD patients, although there is not a differ-
ence in every study.
15,30
Reasons for emergency and hospital admission can
be divided in:
1. Direct disease related morbidity: motor complica-
tions, psychiatric symptoms, autonomic dysfunc-
tion, sensory symptoms, sleep disorders, and side
effects of anti-parkinsonian drugs.
2. Indirect disease related morbidity: traumas and
pneumonia.
3. Non-PD related causes.
As most studies vary greatly in selection of patients,
exact relative proportions of these 3 groups cannot be
assessed (Tables 2 and 3). Some studies found that PD
patients are more likely to be admitted to the ER and
hospital for complications of the disease and its man-
agement than for primary motor problems.
13,18 A part
(5–21%) of the patients were ﬁrst diagnosed to have
PD during a hospitalization.
19,21
Problems During Hospitalization
We found one prospective study on acute events
occurring during hospitalization.
4 When admitted to a
neurology ward (83 PD patients, mean age 69 years,
mean disease duration 6 years), patients received an
average of 0.6 non-neurological consultations. Rea-
sons were: (aspiration) pneumonia, urinary infections
TABLE 1. Pubmed search details
Search Number of hits
Parkinson* and emergenc* 422
Parkinson* and hospitali* 645
Parkinson* and healthcare 892
Parkinson* and hospital admission* 45
Parkinson* and hospital utilization* 4
Parkinson* and resource use 186
Parkinson* and perioperative 93
Parkinson* and preoperative 451
Parkinson* and intraoperative 453
Parkinson* and anesthes* 373
Parkinson* and surgery and cognit* 456
Parkinson* and surgical problems 260
Parkinson* and surgery and apomorphine 289
Parkinson* and postoperative 1231
Parkinson* and surgery and complication* 2241
Medication interruption or drug manipulations OR
discontinuation or dose reduction and levodopa
576
Parkinson* and drug withdrawal 607
Parkinson* and lisuride 268
Parkinson* and medication error 59
Amantadine and intravenous* 106
Rotigotine 247
Parkinson* and fracture 236
Parkinson* and nurse 276
Parkinson* and nurse specialist 26
Parkinson* and orthopaedic 94
Parkinson* and orthopedic* 52
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hypotension, low back pain, and TIA. Specialists con-
sulted most frequently were cardiologists, internal
medicine specialists and orthopaedic surgeons. Acute
events observed during hospitalization on non-neuro-
logical department of 20 patients (mean age 80 years)
after ER visits were: Urinary infection (33%), agita-
tion, confusion and hyperthermia (28%), pressure
ulcers and leg oedema (22%), bowel occlusion and hy-
potension (11%), and dysphagia (6%). Mortality rate
during hospitalization of this last group was 20%. We
found one retrospective study on this subject (173 PD
patients), but this study is unclear on the presence or
absence of complications before the hospital admis-
sion.
21 Problems identiﬁed in this study do accord
however with those described above.
4
Another retrospective study shows that in 74% of
35 emergency hospital admissions of PD patients, their
medication was stopped, omitted or prescribed inap-
propriately with 61% of this group suffering signiﬁ-
cant sequelae. Nonadherence to medication schedules
was a large problem and in 11% of cases antidopami-
nergic medication (metaclopramide) was prescribed.
31
In a study analyzing inpatient falls, the use of anti-
Parkinson’s medication was an evident risk factor (OR
5.04).
32
Apart from the studies above, we found several
opinionated views and reviews on problems during
hospitalization of PD patients. These authors point to
disease ﬂuctuations, stress,
7 and medications like
butyrophenones, phenothiazines, and metoclopramide,
prescribed during hospitalization, as possible causes of
PD exacerbation.
6,33–38 Additionally, sleep disorders,
verbal communication problems, nutritional intake
difﬁculties, and cognitive changes are mentioned as
problem areas.
7,19,39
Perioperative Problems
We found 15 retrospective studies on problems dur-
ing and after surgery in patients with PD, with an em-
phasis on the postoperative period. Of these 15, two
retrospective studies included a control group of non-
PD patients.
25,27 One retrospective study focused on
postoperative confusion
33 and two retrospective stud-
ies on medication errors.
40,41 Another study with 10
patients is actually a case report with 10 PD
patients,
42 and the remaining 9 papers are retrospec-
tive studies on PD patients undergoing orthopaedic
surgery.
29,43–50
The ﬁrst study compared 234 PD patients with a
control group of 40,979, undergoing elective bowel
TABLE 2. Emergency room admissions
Study Inclusion Exclusion
Number of
patients Design Control group ER admissions (%) Reasons ER visit
Vargas et al., 2007
9 PD Hoehn and
Yahr Stage 5
144 Retrospective No 22% in 1 yr Primarily side effects of
anti-Parkinsonian drugs
Parkinsonism
Severe cognitive
dysfunction
Cosentino et al., 2005
10 PD Parkinsonism 130 Retrospective No 22% in 1 yr Injuries 61%, mainly
fractures 37%
Admissions
related to PD
Abdominal pain 6%
Pneumonia, dysphagia,
dyskinesia, epistaxis,
hearing loss, pulp disease, teeth
extraction, lumbago,
pain in joint: all 3%
Martignoni et al., 2004
4 PD Parkinsonism 48 Prospective No All selected patients Cardiovascular 27%
Trauma with fractures 19%
Chest or abdominal problems 19%
Neurological (both related and
unrelated to PD) 17%
Head injury 6%
Hip prothesis displacement 2%
Factor and
Molho, 2000
11
PD 5 Case report No All selected
patients
Severe motor
off periods, dyskinesia,
psychosis, acute confusion,
panic disorder, pain
ER, emergency room; PD, Parkinson’s disease.
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Study Inclusion Exclusion Number Design
Control
group*
Hospital
admissions
Five most frequent
admission reasons
Vossius et al.,
2010
15
PD 108 patients Prospective Yes All selected
patients
PD related symptoms
25%
Vascular disorders
14%: signiﬁcant
less than control group
Pulmonary disorders
including
pneumonia 12%
Trauma 12%: signiﬁcant
more than
control group
Cancer 7%: signiﬁcant
less than
control group
Remark: discharge
diagnosis
instead of admission
diagnosis
Klein et al.,
2009
16
PD 143 patients Retrospective No All selected
patients
Motor
complications 37%
Emergency
admissions to
Neurological
Department
Psychosis 24%
Somatic problems 14%
Guneysel et al.,
2008
13
PD Admissions
resulting
in death
76 patients Prospective No All selected
patients
Trauma 28%
Emergency
hospital
admission
PD diagnosis
during
ER visit
UTI 20%
Cardiovascular 15%
Pneumonia,
cerebrovascular
both 12%
GI 8%
Vargas et al.,
2007
9
PD Hoehn and Yahr stage 5 144 patients Retrospective No 28% programmed
admissions
in 1 year
Complication treatment
Parkinsonism Drug adjustment
Severe cognitive
dysfunction
Louis et al.,
2007
17
Young-onset PD Obstetrical
admissions
714 patients Retrospective Yes All selected
patients
Psychosis 23%:
signiﬁcant more
than control group
18-40 years old Craniotomy 7%:
signiﬁcant more
than control group
Pneumonia, UTI both 6%
Headache or seizure 4%
Rehabilitation 3%:
signiﬁcant
more than
control group
Remark: discharge
diagnosis
instead of
admission diagnosis
(Continued)
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Study Inclusion Exclusion Number Design
Control
group*
Hospital
admissions
Five most frequent
admission reasons
Temlett and
Thompson,
2006
18
PD 761 hospital
admissions
Retrospective No All selected
patients
Primary for PD 15%
Falls and fractures 11%
Pneumonia, cardiac disease
both 10%
GI 9%
Organic brain syndrome 6%
Cosentino
et al., 2005
10
PD Parkinsonism 130
patients
Retrospective No 19% in 1 year Diseases of
digestive system 17%
Admissions
related to PD
Diseases of circulatory
system,
rehabilitation both 14%
Cataract 10%
Injury, chest pain both 7%
Sleep disturbance, epistaxis,
abdominal pain,
osteoarthrosis: all 3%
Woodford and
Walker, 2005
19
PD Parkinsonism 367
patients
Retrospective No 35% in 4 year Cardiovascular 20%
Emergency
hospital
admission
Elective admissions Falls 13%
Day-case procedures Pneumonia 11%
Admissions resulting in
death of patient
UTI 9%
Decreased mobility/
dyskinesia,
psychiatric both 8%
Guttman
et al., 2004
20
PD < 25 years of age 15304
patients
Retrospective Yes 68%
in 6 years
Compared with controls
Use of PD drugs First: aspiration pneumonia
Second: affective psychosis
Third: hip fractures
Fourth: urinary tract disorders
including infections
Fifth: septicemia
Martignoni
et al., 2004
4
PD Parkinsonism 132
patients
Prospective No All selected
patients
Admission to neurological
department
Poor control of PD
symptoms 37%
Neurological 25%
Diagnosis conﬁrmation,
psychiatric complaints both 13%
Sudden worsening of motor
symptoms 7%
Head trauma and fracture 2%
Admission to non-neurological
department
Medical and infectious
illnesses 27%
Traumas with fracture 24%
Cardio-circulatory 22%
Tan et al., 1998
21 PD Drug induced
parkinsonism
173
patients
Retrospective No All selected
patients
Chest infection 22%
Falls 13%
Control of PD symptoms 10%
Parkinson-plus
syndromes
General medical
problems 9%
(Continued)
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during a 6-year period. PD patients had a signiﬁcantly
increased incidence of aspiration pneumonia, urinary-
tract infection, bacterial infections, with odds ratios of
3.8, 2.0, 1.7, respectively. Odds ratios for postopera-
tive delirium and hypotension in PD patients were 2.6
and 2.5, with lesser signiﬁcance. PD patients had a
mortality rate of 7.3%, compared with a 3.8% in the
control group.
25
In the second study with a non-PD control group,
51 PD patients, treated on different surgical depart-
ments, were compared using matched-pair analysis.
There were signiﬁcantly more postoperative falls in
the PD group (18% vs. 4%), and a higher although
not signiﬁcantly increased number of urinary tract
infections (33% vs. 24%), pneumonia (10% vs. 4%),
and also wound infection, urinary retention, respira-
tory insufﬁciency, and postoperative confusion. PD
patients were hospitalized for more days and stayed
on the intensive care unit longer.
27
Another retrospective study showed that 60% of 25
PD patients with no pre-existent mental status abnor-
malities suffered postoperative confusion, some with
hallucinations. The onset of the delirium was often
delayed, 70% after 36 hours. In this study, there was
no relationship between delirium and type of anti-Par-
kinson medication or anaesthetic procedure.
33
In a retrospective study on pharmacological manage-
ment during 51 surgical admissions of PD patients or
patients with parkinsonian syndromes treated with PD
medication, 71% had missed doses of their medica-
tion. Overall, antidopaminergic medication was pre-
scribed in 41% and administrated in 22% although
not allowed. 47% (69% for non-day-cases admissions)
had complications: neuropsyciatric 41%, falls 8%,
and worsening of motor symptoms 5%.
40 A second
study on pharmacological management found that
30% of 92 PD patients had medication administration
problems, leading to an increase in postoperative con-
fusion or worsening of PD: 84% to 36% in the well-
managed group. Overall 31% of patients was dissatis-
ﬁed in the way their PD was managed in the perioper-
ative period.
41
In the smallest study (n ¼ 10), all patients had com-
plications. This paper identiﬁed the same problems as
mentioned above, and additionally found pressure
sores as an important problem.
42
Next to the above studies, there are nine retrospec-
tive research articles on orthopaedic surgery and its
complications. These studies (totalling 433 PD
patients, Table 4) found pneumonia, urinary tract
infections, confusion, and decubitus as the most fre-
quent postoperative complications, in frequencies up
to 49%
44–50 with an overall six month mortality up to
47%.
44,45,47,48,50,51 Apart from complications, several
studies are contradictory regarding the outcome of
orthopaedic procedures in PD patients,
26,29,30,43–60
and postoperative rehabilitation is reported to be
slower.
28,55
Next to these more or less formal surveys, case
report and reviews mention the following periopera-
tive problems: neuroleptic malignant syndrome, medi-
cation- or anaesthetic-induced exacerbation of PD,
side-effects of PD medication, postextubation laryn-
geal spasm, bronchospasm, respiratory arrest, difﬁ-
culty with salivation, gastrointestinal complications,
deep vein thrombosis, urinary disturbances, tempera-
ture regulation problems, and tremor hampering eye
surgery.
6,8,34–38,61–80
Improvement of Care for the Hospitalized
PD Patient
Improvement During Hospitalization
There are no studies analyzing the effects of sug-
gested recommendations/improvements. Some authors
favour a multidisciplinary approach during hospitali-
zation.
4,7 Other suggestions are: continuing the exact
TABLE 3. (Continued)
Study Inclusion Exclusion Number Design
Control
group*
Hospital
admissions
Five most frequent
admission reasons
Urinary
dysfunction 8%
Kessler 1972
22 PD 468 patients Retrospective Yes All selected
patients
PD 19%
Paralysis agitans Circulatory system 16%
Parkinsonism Digestive system 10%
Accidents 9%
Respiratory system 8%
Remark: Neoplasm 4%:
signiﬁcant less than
control group
*Comparison with inclusion group concerning admission reasons.
PD, Parkinson’s disease, UTI, urinary tract infection, GI, gastrointestinal.
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Study Inclusion Exclusion Number Design Intervention
Most frequent
complications
Mehta et al., 2008
29 PD Total knee
arthroplasty
revision
34 patients Retrospective Total knee
arthroplasty
Confusion 35%
39 knees Superﬁcial wound infection,
aspiration pneumonia both 6%
Weber et al., 2002
48 PD 98 patients Retrospective Hip
replacement
6 Month mortality 6%
107 hips Overall complications: 36%
UTI 7%
Dislocation 6%
Postoperative confusion 4%
Pneumonia, deep venous
thrombosis both 3%
Duffy and Trousdale, 1996
43 PD 24 patients Retrospective Total knee
arthroplasty
Confusion 20%
33 knees Deep venous thrombosis, superﬁcial
infections both 8%
Myositis ossiﬁcation, urinary retention,
wound necrosis, respiratory tract
infection all 4%
Turcotte et al., 1990
50 PD 87 patients Retrospective Hip fracture
surgery
After 6 months:
94 hips Mortality 14%: myocardial infarction (n¼5),
infection (n¼2), pulmonary embolism
(n¼1), unknown (n¼4)
Orthopaedic problem 14%
Decubitus ulcers 5%
Wound infections 4%
Vince et al., 1989
46 PD 9 patients Retrospective Total knee
arthroplasty
Deep vein thrombus (n¼4), UTIs
(n¼3), temporary disorientation
(n¼2), skin necrosis (n¼1), intestinal ileus
(n¼1), pulmonary embolism (n¼2)
13 knees
Staeheli et al., 1988
45 PD Parkinsonism 49 patients Retrospective Hip fracture
surgery
6 Months complication:
50 hips Mortality 20%: pneumonia 40%,
congestive heart failure 20%,
cerebrovascular accident 20%,
pulmonary embolism 10%,
breast cancer 10%
UTI 20%, pneumonia 10%, decubitus
ulcers 10%, pulmonary embolism 6%,
cerebrovascular accident 6%, wound
infection 4%
Eventov et al., 1983
44 PD Impacted
subcapital
fractures
62 patients:
45 patients
undergoing
surgery
Retrospective Hip fracture
surgery
3 Month mortality surgery group
31% (1 year 38%): bronchopneumonia
43%, congestive heart failure 21%
Ambulatory 3 Month mortality in patients not
undergoing surgery 29% (35% 1 year)
Survivors surgery
group (n¼31):
UTI 23%, decubitus 23%,
bronchopneumonia
(Continued)
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doctors, being attentive for early signs of complica-
tions like pneumonia to start early treatment, falling
prevention, (temporary) medication adjustment, emo-
tional support, good sleep hygiene by maintaining the
home bedtime and trying to prevent sleeping during
the day, sometimes consulting a sleep disorder special-
ist or start sleeping medication, exercise, speech ther-
apy, sufﬁcient nutritional intake high in ﬁbre,
adequate ﬂuid intake, preventing a confusional state
by limiting the number of care-givers and the amount
of light and noise during night sleeping, avoiding cer-
tain medication harmful for the PD patient, and con-
sulting a neurologist.
7,21,31,35,37,67
Improvement of Perioperative Care
There are only two studies on medication continua-
tion during surgery
81,82 and one study analyzing the
effect of an early postoperative neurologic consulta-
tion,
29 and numerous case reports, and opinionated
views and reviews.
During preoperative screening, some authors rec-
ommend extra attention to be paid to this group
of patients, especially to respiratory status, urologic
system, ﬂuid status, cardiovascular system, gas-
trointestinal system, autonomic system, and cogni-
tion.
6,25,35,37,66,73,74,78,83 And, if necessary, supple-
mented with additional diagnostics like laboratory
tests, pulmonary tests, electrocardiogram, and X-
ray.
25,66,73,78 Most of the literature describes meas-
u r e sw i t hr e g a r dt oP Dm e d i c a t i o ni nt h ei n t r a o p e r a -
tive period. To prevent large descents of dopamine
levels intra- and postoperatively many authors advise
continuation of PD medication as long as possible
preoperatively and resume it as soon as possible post-
operatively, and PD medication is preferably contin-
ued.
6,8,25,34,37,38,42,67–70,72–74,76,78,79,81,82,84–92 Two
studies on this topic describe PD patients using the
rotigotine transdermal patch, a nonergot D1/D2/D3
dopamine agonist.
81,82 In the ﬁrst prospective study,
oral dopaminergic medication was easily switched to
rotigotine before surgery and resumed afterwards in
14 PD patients undergoing surgery under general
anaesthesia. Adverse events were two dopaminergic
side effects namely nausea and hallucinations and
one ventricular asystole.
81 The second study on this
topic describes PD patients derived from two pro-
spective clinical trails. PD patients undergoing sur-
gery under general anaesthesia and who continued
using rotigotine during surgery were retrospectively
analyzed (n ¼ 25). There was no worsening of PD
symptoms, but (only) three complications: deep vein
thrombosis, infection, and pain.
82
As other substitutes for dopaminergic medication in-
traoperatively, continuous intravenous levodopa
TABLE 4. (Continued)
Study Inclusion Exclusion Number Design Intervention
Most frequent
complications
16%, contractures 6%,
deep infection,
cardiac arrythmias, myocardial
infarction, dislocation,
thrombophlebitis, paralytic
ileus all 3%
Survivors of patients not
undergoing surgery (n¼12):
UTI 17%, decubitus 25%,
bronchopneumonia 0%,
contractures 17%
Coughlin and
Templeton, 1980
47
PD 47 patients Retrospective Hip fracture
surgery
6 Month mortality 47%
49 hips Decubitus 49%
Ambulatory Dislocation 37%
(endoprosthesis)
Rothermel and
Garcia, 1972
49
PD 23 patients:
16 without
levodopa,
7 with levodopa
Retrospective Hip fracture
surgery
With levodopa: phlebitis n¼1
Without levodopa: debrided decubitus
ulcers n¼2, phlebitis n¼2,
deep hematoma n¼2, dislocation
n¼2, urinary septicaemia
n¼1, fatal myocardial infarction n¼1
PD, Parkinson’s disease; UTI, urinary tract infection.
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ate postoperative injections of apomorphine, and
enteral levodopa/carbidopa via nasogastric tube or duo-
denostomy have been used by various
authors,
68,69,72,76,78,88,92,93 but none have been studied
in a controlled trial. The use of parenteral anticholiner-
gic and antihistaminic medication as anti-Parkinson
therapy is limited according to some authors, and may
aggravate postoperative discomfort because of auto-
nomic side effects and confusion.
72,76,78
Some authors claim that general anaesthesia should
be avoided when possible, and prefer local anaesthe-
sia.
37,66,67,73,75,90 This is supported by a case report of
a PD patient, undergoing surgery with regional anaes-
thesia, who was successfully given levodopa and carbi-
dopa orally during the operation.
86 Regional
anaesthesia also avoids postoperative nausea and vom-
iting.
73 Less invasive interventions, like laparoscopic
surgery over abdominal surgery, are recommended.
66
Some authors advocate carefully considering the used
operation technique.
47,50
In a retrospective study, the postoperative period
was analyzed in PD patients undergoing total knee
arthroplasty receiving a preoperative or immediate
postoperative neurologic consultation (n ¼ 13) com-
pared with patients receiving a delayed or no visit (n
¼ 21). Only in the ﬁrst group, there was a signiﬁcant
improvement in total Uniﬁed Parkinson’s Disease Rat-
ing Scale with most improvement in activities of daily
living but also an improvement of mood, mentation
and behavior, and motor examination. In this group,
there was also a shorter length of stay (P < 0.01) and
less patients were confused: 15 to 48%.
29
There are many more recommendations, without
formal studies. Postoperatively lung expansion
manoeuvres, noninvasive mechanical ventilation, per-
cussion, adequate pain control, aspiration precautions,
(early) mobilization, recognition of unique physical
limitations and medication combinations, physiother-
apy, turning regimens, maintenance of volume status,
antiparkinsonian therapy adjustments, analyzing urine
for urinary tract infections, and deep venous thrombo-
sis prophylaxis may prevent complications like pulmo-
nary emboli, infections, deep vein thrombosis and
decubitus.
6,27,42–45,50,55,59,60,66,72,74,78,83,91,94–96 In
case of prolonged endotracheal intubation early tra-
cheostomy is preferred.
66 Except for two case reports,
there is no literature concerning the pre-emptive
administration of drugs to prevent complications. In
one case report, the cholinesterase inhibitor rivastig-
mine was given preoperatively to prevent delirium
postoperatively in a PD patient successfully treated
with this drug in two previous delirious episodes.
97 In
another case report, prokinetics were administered in
two patients to prevent paralytic ileus.
92 Some authors
suggest preventive antibiotics to prevent infec-
tions.
44,45,59 As described before, the onset of the
postoperative delirium is often delayed. If patients are
discharged rapidly after surgery, there should be sufﬁ-
cient support in the home environment.
33 Overall,
team work between different specializations, like sur-
gery, neurology, geriatrics, and a rehabilitation unit is
generally advocated.
28,96,98
Discussion
There are few studies analyzing the problems a PD
patient encounters during hospitalization, and there
are even less studies analyzing possible solutions.
Most studies are retrospective and have small numbers
of patients. In some studies, PD patients were
diagnosed according to clear diagnostic criteria (like
the United Kingdom Parkinson’s Disease Society
Brain Bank’s clinical diagnostic criteria),
4,9–11,15,19,48
but in most studies, the diagnostic criteria were not
clearly mentioned: a neurologist conﬁrmed the
diagnosis,
13,43,45,46,48 or medical record systems and/
or patients notes were used to identify PD
patients,
17,20–22,25,27,33,40 or no information according
to the diagnostic criteria, except the use of PD medica-
tion, was given.
16,31,41,42,47,49,50,81,82
Overall PD patients are more frequently
20,23,24 and
longer
12,16,17,19,21,24–29 hospitalized compared with
controls. Generally the leading causes for admission
are injuries (many with fractures), infections [mainly
pneumonia and urinary tract infections (UTI)], poor
control of PD and complications of PD treatment, psy-
chiatric disturbances, and diseases of the circulatory
and digestive system. A reduction of the number of
admissions might be achieved by extra attention to
fall prevention, adequate drug regulation with acuity
for side effects, preventing and recognizing of early
symptoms of infections and active monitoring in the
home situation of both patients’ vital parameters and
therapy compliance.
5,18,20 When admitted to a hospi-
tal, most PD patients stay on a general medicine or
surgery ward instead of a neurological one.
5,15 Apart
from one small prospective study
4 and a retrospective
study,
31 little is known about problems occurring dur-
ing hospitalization of PD patients not undergoing sur-
gery, mentioning the usual direct and indirect PD
related problems and medication issues.
There are more studies on complications in PD
patients hospitalized for surgery, particularly in the
postoperative period. (Aspiration) pneumonia, UTI,
bacterial infections, postoperative falls, postoperative
delirium/confusion (often with a delayed onset
33), and
hypotension occur more frequently in this group of
patients than in controls.
25,27 Pressure sores are also
an important complication.
42 Mortality rates are also
higher.
25 These data are conﬁrmed by studies on PD
patients undergoing orthopaedic surgery.
29,43–50 Many
PD patients had postoperative medication
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fusion or worsening of PD as a result.
40,41 It is striking
that almost one third of the PD patients were dissatis-
ﬁed concerning their PD treatment.
41
Suggestions for Improvement of Hospital Care
There are many proposals for improvement during
hospitalization in PD patients with or without surgery.
Suggestions on improvement do vary, but most
authors agree that attention should be given to all
aspects of PD and not only to motor function.
Most publications refer to the intraoperative period
mainly to prevent a decline in dopamine levels because
of discontinuation of dopaminergic medication,
including two studies favouring the use of a rotigotine
patch.
81,82 Most authors agree that anesthesiologists
and surgeons should take the increased vulnerability
of PD patients into account when planning and select-
ing procedures.
37,47,50,66,67,73,75,86,90 One small study
shows that early consultation by a neurologist may
prevent complications and reduce length of hospital
stay.
29
Conclusions
Most studies were retrospective and had small num-
bers. Prospective studies with large numbers of PD
patients, deﬁned according to clear diagnostic criteria
and preferable diagnosed by a specialist with special
interest in PD, would be preferred for future research.
Generally patients with PD are hospitalized much
more frequently and longer than control groups. The
leading causes are injuries, infections, poor control of
PD and complications of PD treatment. The inclusion
of hospitalization data into patient registries for PD
could be a major improvement in identifying the im-
portant problems.
There are many (un-researched) proposals for
improvement during hospitalization in PD patients. A
substantial number of PD patients’ admissions might
be prevented. There should be guidelines concerning
the hospitalized PD patients, with accent on early neu-
rological consultation or consultation of another spe-
cialist like a geriatrician with a special interest in PD
and team work between different specialities, and on
sufﬁcient training of all people involved in the treat-
ment and recovery of this patient group. This protocol
should include dopaminergic replacement therapy in
case PD patients are not allowed or able to take their
oral medication. Preferably this therapy should not be
laborious and not invasive so that it is easily
applicable.
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